Printer Friendly

BIOWHITTAKER ANNOUNCES FIRST QUARTER RESULTS

 BIOWHITTAKER ANNOUNCES FIRST QUARTER RESULTS
 WALKERSVILLE, Md., Feb. 24 /PRNewswire/ -- BioWhittaker, Inc.


(NYSE: BWI), today announced the results of its operations for the first quarter of fiscal 1992 which ended Jan. 31, 1992.
 -- Actual Results for the Quarter Ended Jan. 31, 1992
 Net income for the quarter amounted to $1,078,000, or 10 cents per share. Sales for the first quarter were $12,100,000, compared to $8,540,000, for the same quarter a year ago.
 -- Pro Forma Results for the Quarter Ended Jan. 31, 1991
 BioWhittaker was a wholly owned subsidiary of Whittaker Corporation (NYSE: WKR) through the end of fiscal 1991. As previously announced, Whittaker spun off all of its interest in BioWhittaker to Whittaker's stockholders of record on Nov. 14, 1991.
 If BioWhittaker had been an independent company during the first quarter of 1991 and if the September 1991 acquisition of the assets and business of 3M Diagnostic Systems, Inc., had occurred at the beginning of fiscal 1991, results of operations for the three months ended Jan. 31, 1991, on a pro forma basis, would have reflected net income of $503,000, or 5 cents per share, and sales of $10,429,000.
 These pro forma figures are derived from the historical financial statements as adjusted for the pro forma results of operations of 3M Diagnostic Systems prior to its acquisition by BioWhittaker, the elimination of Whittaker corporate charges, the addition of estimated expenses that BioWhittaker would have incurred as a stand alone entity, and estimated income tax provisions related to the historical results and the foregoing adjustments. They are presented for illustrative purposes only and are not necessarily indicative of the operating results had the spin-off of BioWhittaker and the acquisition of 3M Diagnostic Systems occurred at the beginning of the periods indicated.
 BIOWHITTAKER, INC.
 Consolidated Statements of Income
 (Unaudited)
 (Dollars in Thousands, Except Share Data)
 For the Three Months Ended Jan. 31,
 1992 1991
 Sales $12,100 $ 8,540
 Costs and expenses
 Cost of sales 5,898 4,657
 Research and development 646 409
 Selling, general and administrative 3,592 2,385
 Interest on long-term debt 179 64
 Total 10,315 7,515
 Income Before Corporate Charges
 and Income Taxes 1,785 1,025
 Corporate charges
 Administrative charge -- 125
 Asset utilization charge -- 701
 Total -- 826
 Income Before Provision
 for Income Taxes 1,785 199
 Provision for income taxes(A) 707 --
 Net Income $ 1,078 $ 199
 Earnings Per Share(B) $ .10 $ --
 Average Common and Common
 Equivalent Shares Outstanding
 (in thousands) 11,169 --
 (A) BioWhittaker, as a wholly owned subsidiary of Whittaker Corporation during fiscal 1991, was included in Whittaker Corporation's consolidated income tax returns. Since Whittaker Corporation does not have a tax sharing agreement with its subsidiaries, the above historical statement of income for the three months ended Jan. 31, 1991, does not reflect a provision for income taxes. If income taxes for BioWhittaker were calculated using the separate return method, the provision for income taxes for the three months ended Jan. 31, 1991, would be approximately $78,000.
 (B) Prior to the spin-off, BioWhittaker did not have a meaningful capital structure for purposes of computing earnings per share. Accordingly, earnings per share data for the quarter ended Jan. 31, 1991, are not presented.
 Consolidated Balance Sheet
 Jan. 31, 1992
 (Unaudited)
 (Dollars in thousands)
 ASSETS
 Current Assets
 Cash $ 456
 Accounts receivable 8,766
 Inventories 17,687
 Prepaid expenses 568
 Deferred income taxes 372
 Total Current Assets 27,849
 Property, Plant and Equipment 23,903
 Less accumulated depreciation and amortization 12,007
 Total Property, Plant and Equipment 11,896
 Other Assets
 Intangibles 8,665
 Miscellaneous 105
 Total 8,770
 Total Assets $48,515
 LIABILITIES AND STOCKHOLDERS' EQUITY
 Current Liabilities
 Current portion of long-term debt $ 6,632
 Accounts payable 3,329
 Accrued liabilities 4,267
 Income taxes payable 826
 Total Current Liabilities 15,054
 Long-Term Debt 2,379
 Deferred Income Taxes 768
 Stockholders' Equity 30,314
 Total Liabilities $48,515
 -0- 2/24/92
 /CONTACT: Philip L. Rohrer of BioWhittaker, Inc., 301-898-7025, ext. 2352/
 (BWI WKR) CO: BioWhittaker, Inc. ST: Maryland IN: SU: ERN


SB-TW -- DC001 -- 1721 02/24/92 08:51 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 24, 1992
Words:687
Previous Article:FIRST EMPIRE AGREES TO ACQUIRE TWO MIDLANTIC BANKS
Next Article:BALL CORPORATION WILL INCREASE INVESTMENT IN GROWING CHINESE BEVERAGE CONTAINER INDUSTRY
Topics:


Related Articles
NOEL L. BUTERBAUGH NAMED CEO OF BIOWHITTAKER, INC; OTHER EXECUTIVE CHANGES ALSO ANNOUNCED
BIOWHITTAKER REPORTS PROJECTED EARNINGS
BIOWHITTAKER ANNOUNCES THIRD QUARTER RESULTS
BIOWHITTAKER ANNOUNCES FIRST QUARTER RESULTS
BIOWHITTAKER ANNOUNCES RECORD EARNINGS
BioWhittaker Announces Improved Third Quarter Earnings
Jury Finds For 3M In BioWhittaker's Suit Against 3M
BioWhittaker Reports Strong First Quarter Fiscal 1997 Operating Results
BioWhittaker Announces Strong Third Quarter Sales and Earnings

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters